51626 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 13
15:19 UTC
|
FIVE
Five Below
|
↓ Downgrade | firm only | Neutral | |
|
Aug 13
15:19 UTC
|
FIVE
Five Below
|
↓ Downgrade | Spencer Hanus ★★★☆☆ #1919 | Outperform→ Peer Perform | |
|
Aug 13
15:19 UTC
|
SLGN
Silgan
|
↑ Upgrade | Arun Viswanathan ★★★☆☆ #1698 | Sec→ r Perform ➝ Outperform | $51.00→ $58.00+13.7% |
|
Aug 13
15:19 UTC
|
FIVE
Five Below
|
↑ Upgrade | Paul Lejuez ★★★☆☆ #1979 | Market Perform→ Buy | |
|
Aug 13
15:19 UTC
|
CLB
Core Laboratories
|
↑ Upgrade | firm only | Hold→ Buy | $21.00 |
|
Aug 13
15:19 UTC
|
CIB
Grupo Cibest
|
↑ Upgrade | firm only | Neutral→ Buy | |
|
Aug 13
15:19 UTC
|
AKAM
Akamai Technologies
|
↑ Upgrade | Samik Chatterjee ★★★☆☆ #2104 | Underweight→ Neutral | $132.00→ $158.00+19.7% |
|
Aug 13
14:19 UTC
|
VGNT
Versigent
|
◎ Target | Bill Selesky ★★☆☆☆ #2640 | Buy | $50.00→ $54.00+8.0% |
|
Aug 13
14:19 UTC
|
TRAX
First Tracks Biotherapeutics
|
◎ Target | Martin Fan ★★☆☆☆ #2568 | Outperform | $60.00→ $70.00+16.7% |
|
Aug 13
14:19 UTC
|
STRO
Sutro Biopharma
|
◎ Target | Reni J. Benjamin not yet tracked | Market Outperform | $41.00→ $34.00-17.1% |
|
Aug 13
14:19 UTC
|
STAA
STAAR Surgical
|
◎ Target | Michael Piccolo ★★☆☆☆ #2679 | Outperform | $40.00→ $37.00-7.5% |
|
Aug 13
14:19 UTC
|
SPRB
Spruce Biosciences
|
◎ Target | Jonathan Wolleben ★☆☆☆☆ #3055 | Market Outperform | $150.00→ $144.00-4.0% |
|
Aug 13
14:19 UTC
|
RSKD
Riskified
|
◎ Target | Ryan Tomasello ★★★☆☆ #1743 | Market Perform | $5.50→ $6.25+13.6% |
|
Aug 13
14:19 UTC
|
RRGB
Red Robin Gourmet Burgers
|
◎ Target | Todd M. Brooks not yet tracked | Buy | $8.00→ $10.00+25.0% |
|
Aug 13
14:19 UTC
|
PTCT
PTC Therapeutics
|
◎ Target | Benjamin Burnett ★★★☆☆ #1374 | Overweight | $106.00→ $109.00+2.8% |
|
Aug 13
14:19 UTC
|
PR
Permian Resources
|
◎ Target | Hanwen Chang ★★★☆☆ #1095 | Overweight | $26.00→ $27.00+3.8% |
|
Aug 13
14:19 UTC
|
PLGO
Fidelis Insurance
|
◎ Target | Matthew J. Carletti not yet tracked | Market Outperform | $28.00→ $29.00+3.6% |
|
Aug 13
14:19 UTC
|
PHVS
Pharvaris
|
◎ Target | Jonathan Wolleben ★☆☆☆☆ #3055 | Market Outperform | $74.00→ $75.00+1.4% |
|
Aug 13
14:19 UTC
|
OVV
Ovintiv
|
◎ Target | Hanwen Chang ★★★☆☆ #1095 | Overweight | $80.00→ $78.00-2.5% |
|
Aug 13
14:19 UTC
|
OSCR
Oscar Health
|
◎ Target | Stephen Baxter ★★★★☆ #670 | Equal Weight | $20.00→ $27.00+35.0% |
|
Aug 13
14:19 UTC
|
MUR
Murphy Oil
|
◎ Target | Hanwen Chang ★★★☆☆ #1095 | Equal Weight | $42.00→ $45.00+7.1% |
|
Aug 13
14:19 UTC
|
MTW
Manitowoc
|
◎ Target | Jerry Revich ★★★☆☆ #1404 | Underweight | $10.00→ $12.00+20.0% |
|
Aug 13
14:19 UTC
|
MTDR
Matador Resources
|
◎ Target | Sam Margolin ★★★★★ #284 | Equal Weight | $63.00→ $79.00+25.4% |
|
Aug 13
14:19 UTC
|
MSGE
Madison Square Garden Entertainment
|
◎ Target | Joseph Stauff ★★☆☆☆ #2644 | Positive | $80.00→ $103.00+28.7% |
|
Aug 13
14:19 UTC
|
MRX
Marex Group plc Ordinary Shares
|
◎ Target | Chris Allen not yet tracked | Outperform | $80.00→ $90.00+12.5% |
|
Aug 13
14:19 UTC
|
MGY
Magnolia Oil & Gas
|
◎ Target | Hanwen Chang ★★★☆☆ #1095 | Equal Weight | $31.00→ $36.00+16.1% |
|
Aug 13
14:19 UTC
|
MBI
MBIA
|
◎ Target | Tommy McJoynt not yet tracked | Outperform | $7.50→ $7.00-6.7% |
|
Aug 13
14:19 UTC
|
LQDA
Liquidia
|
◎ Target | Benjamin Burnett ★★★☆☆ #1374 | Overweight | $62.00→ $108.00+74.2% |
|
Aug 13
14:19 UTC
|
LFTO
Liftoff Mobile
|
◎ Target | Alec Brondolo ★★★☆☆ #1972 | Overweight | $32.00→ $34.00+6.2% |
|
Aug 13
14:19 UTC
|
KURA
Kura Oncology
|
◎ Target | Robert Driscoll ★★☆☆☆ #2656 | Outperform | $36.00→ $38.00+5.6% |
|
Aug 13
14:19 UTC
|
HUMA
Humacyte
|
◎ Target | Bruce D. Jackson not yet tracked | Speculative Buy | $2.00→ $1.00-50.0% |
|
Aug 13
14:19 UTC
|
HCAT
Health Catalyst
|
◎ Target | Stan Berenshteyn ★★★★☆ #691 | Equal Weight | $1.75→ $1.50-14.3% |
|
Aug 13
14:19 UTC
|
GO
Grocery Outlet
|
◎ Target | Edward Kelly ★★★☆☆ #1604 | Equal Weight | $9.00→ $11.00+22.2% |
|
Aug 13
14:19 UTC
|
FWRD
Forward Air
|
◎ Target | Bascome Majors ★★☆☆☆ #2449 | Positive | $18.00→ $29.00+61.1% |
|
Aug 13
14:19 UTC
|
FWDI
Forward Industries
|
◎ Target | Fedor Shabalin ★★☆☆☆ #2575 | Buy | $8.00→ $7.00-12.5% |
|
Aug 13
14:19 UTC
|
ETOR
eToro Group
|
◎ Target | James Friedman ★★★☆☆ #2133 | Positive | $57.00→ $51.00-10.5% |
|
Aug 13
14:19 UTC
|
ENVX
Enovix
|
◎ Target | Ryan Pfingst ★☆☆☆☆ #3163 | Buy | $10.00→ $9.00-10.0% |
|
Aug 13
14:19 UTC
|
EAT
Brinker International
|
◎ Target | Zachary Fadem ★★★☆☆ #1716 | Overweight | $220.00→ $280.00+27.3% |
|
Aug 13
14:19 UTC
|
DVN
Devon Energy
|
◎ Target | Hanwen Chang ★★★☆☆ #1095 | Overweight | $68.00→ $65.00-4.4% |
|
Aug 13
14:19 UTC
|
DFTX
Definium Therapeutics
|
◎ Target | Benjamin Burnett ★★★☆☆ #1374 | Overweight | $68.00→ $72.00+5.9% |
|
Aug 13
14:19 UTC
|
CSCO
Cisco Systems
|
◎ Target | Aaron Rakers ★★★☆☆ #1262 | Overweight | $130.00→ $150.00+15.4% |
|
Aug 13
14:19 UTC
|
CSCO
Cisco Systems
|
◎ Target | Tim Long ★★★☆☆ #1493 | Equal Weight | $121.00→ $123.00+1.7% |
|
Aug 13
14:19 UTC
|
CRGY
Crescent Energy
|
◎ Target | Hanwen Chang ★★★☆☆ #1095 | Overweight | $18.00→ $24.00+33.3% |
|
Aug 13
14:19 UTC
|
CHRD
Chord Energy
|
◎ Target | Hanwen Chang ★★★☆☆ #1095 | Overweight | $175.00→ $163.00-6.9% |
|
Aug 13
14:19 UTC
|
CGEM
Cullinan Therapeutics
|
◎ Target | Robert Driscoll ★★☆☆☆ #2656 | Outperform | $39.00→ $42.00+7.7% |
|
Aug 13
14:19 UTC
|
CBRS
Cerebras Systems
|
◎ Target | Matt Bryson ★★★☆☆ #2147 | Outperform | $280.00→ $290.00+3.6% |
|
Aug 13
14:19 UTC
|
BTGO
BTGO
|
◎ Target | Steven Wahrhaftig ★★★★★ #245 | Outperform | $15.00→ $8.00-46.7% |
|
Aug 13
14:19 UTC
|
BTGO
BTGO
|
◎ Target | Cassie Chan ★★★☆☆ #1252 | Overweight | $13.00→ $11.00-15.4% |
|
Aug 13
14:19 UTC
|
BTDR
Bitdeer Technologies Group
|
◎ Target | Stephen Glagola ★☆☆☆☆ #2925 | Market Perform | $14.00→ $10.00-28.6% |
|
Aug 13
14:19 UTC
|
BTDR
Bitdeer Technologies Group
|
◎ Target | Nick Giles ★☆☆☆☆ #3234 | Buy | $23.00→ $21.00-8.7% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.